Location Institution* BSL-3 BSL-3+ BSL-4 Select Agent Tier I GLP≠ GMP
Duke U Human Vaccine Institute Regional Biocontainment Laboratory (RBL) Y Y N Y Y Y N
Colorado State University RBL Y Y N Y Y Limited Y
University of Pittsburgh, Center for Vaccine Research RBL Y Y N Y Y N N
University of Alabama Birmingham Southeast Biosafety Laboratory Alabama (SEBLAB) Y N N Y Y N N
University of Chicago The Howard T. Ricketts Laboratory (HTRL) Y Y N Y Y N N
University of Medicine and Dentistry of New Jersey RBL Y N N Y Y Y N
University of Missouri-Columbia RBL Y N N Y Y N N
Tufts University/New England RBL (NE-RBL) Y N N Y ? N N
Tulane National Primate Research Center RBL Y Y N Y Y N N
University of Tennessee Health Science Center RBL Y N N Y Y Y N
University of Louisville Center for Predictive Medicine RBL Y Y N Y Y Y Limited
George Mason University/Biomedical Research Laboratory (BRL) Y N N Y Y Y N
University of Texas Medical Branch at Galveston/National Laboratory (GNL) Y Y Y Y Y Y N
Boston University# National Emerging Infectious Diseases Laboratory (NEIDL)# Y Y Y Y Y N N
*At the writing of this review The University of Hawaii RBL had not yet begun construction. #The Boston University NEIDL had been completed and occupied at BSL2; date for occupancy at BSL3/4 was pending. ≠GLP-good laboratory practice, good manufacturing practice
Table 2: Institutional regulatory capability.